- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
20 Stocks Moving in Tuesday's Pre-Market Session
March 29, 2022
From Benzinga
From Benzinga
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
March 28, 2022
From Benzinga
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
1 Green Flag for Take-Two Interactive, and 1 Red Flag
March 26, 2022
From Motley Fool
From Motley Fool
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
March 21, 2022
From Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
From Benzinga
5 Unexpected Sources of Retirement Income
March 20, 2022
From Motley Fool
Regulus Moving Closer To Potential $25 Million Milestone Payment For Novel Kidney Disease Treatment Licensed To Sanofi
March 18, 2022
From Benzinga
1 Great Income Stock to Buy and Hold Forever
March 16, 2022
From Motley Fool
From Benzinga
From Benzinga
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
From Benzinga
Is Regeneron Stock a Buy Now?
March 11, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
3 Top Healthcare Stocks to Buy for March
March 06, 2022
From Motley Fool
From Motley Fool
From Benzinga
Viatris Just Snagged a Major FDA Approval
March 03, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.